Clinical Trial Update: CYCLosporinE A in Reperfused Acute Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Cyclosporine A in reperfused acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Cyclosporine A (cyclosporine)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Acute Myocardial Infarction | Phase 3 | Status: COMPLETED